[Samsung Q3 operating profit surges 783%, AI memory boom drives chip business profitability]

According to The Wall Street Journal, citing people familiar with the matter, Broadcom (AVGO.O) has in recent weeks been seeking more than $50 billion in financing for custom AI chips co-developed with OpenAI, and institutions including Apollo and Blackstone have held discussions about participating in the financing. Negotiations are still in an early stage, and the financing size may be adjusted. The financing could cover several gigawatts of OpenAI custom chip capacity and is expected to be completed as early as the end of this year. OpenAI internally calls the chip project "Nexus," with the first- and second-generation chips codenamed Jalapeño and Serrano, respectively. OpenAI and Broadcom previously announced a partnership to develop a 10-gigawatt custom chip system, with deployment planned to run from H2 2026 through the end of 2029.

The National Health Commission and the National Development and Reform Commission (NDRC) have issued the Implementation Plan for the Expansion and Upgrading Project of Medical Rehabilitation and Nursing Care. The plan mentions strengthening the R&D and application of innovative products. It encourages leading enterprises in the industry, universities, research institutes, and medical and health institutions to build industry-academia-research-application innovation consortia and to intensify the commercialization of innovative achievements. Focusing on key areas such as neurological rehabilitation, sports rehabilitation, and wound repair, it calls for accelerating the deployment of cutting-edge technologies including brain-computer interfaces, embodied AI, and biomimetic actuation, and supports key technological breakthroughs in intelligent rehabilitation equipment, implantable and interventional devices, and new-type biomaterials. It also calls for the R&D of intelligent rehabilitation and nursing products of traditional Chinese medicine that integrate TCM theory with modern technology. The plan promotes the inclusion of eligible innovative medical devices and drugs for rehabilitation and nursing into the priority review and approval process in accordance with procedures. It encourages high-level hospitals to play a leading role, summarize application experience of products such as brain-computer interfaces, and strengthen the implementation and application of innovative rehabilitation and nursing achievements in settings including medical and health institutions, communities, and households.